Bryan Lo
Ottawa, ON K1H8L6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC.
Journal: Current oncology (Toronto, Ont.)
Published: June 16, 2026
Primary Nodal Poroid Hidradenocarcinoma With YAP1::NUTM1 Fusion: Report of a Rare Case.
Journal: Journal of cutaneous pathology
Published: May 14, 2026
Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: April 23, 2026
Coexistent Endometrial and Fallopian Tube Carcinoma: Molecular and Pathological Features for Risk Stratification.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 23, 2026
Targeted transcriptome profiling of oral cavity squamous cell carcinoma and histologic grade-associated gene expression patterns.
Journal: Journal of clinical pathology
Published: January 02, 2026
Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors.
Journal: Current oncology (Toronto, Ont.)
Published: November 01, 2025
Dominant Negative PTEN Alterations in Endometrial Carcinoma Are Associated With Retained Immunohistochemical PTEN Expression.
Journal: The American journal of surgical pathology
Published: May 22, 2025
Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management.
Journal: JTO clinical and research reports
Published: January 15, 2025
Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada.
Journal: Cancer treatment and research communications
Published: November 28, 2024
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.
Journal: Therapeutic advances in medical oncology
Published: October 08, 2024
Internal Standards for Limit Controls and Absolute Abundance Measurement of Oncogenic Fusions and Mutations.
Journal: The journal of applied laboratory medicine
Published: September 08, 2023
Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.
Journal: Current oncology (Toronto, Ont.)
Published: August 15, 2023
Last Updated: 09/26/2026